Reaction
Ankle Arthroplasty reporting signals
As of the last recalculation, Ankle Arthroplasty appears in 354 FAERS reports alongside 30 co-occurring drug terms. The strongest observed disproportionality signal is ANAKINRA (PRR 459.9).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Anakinra | 95 | 459.9 | 462.5 |
| Cortisone Acetate | 55 | 309.9 | 311.3 |
| Desoximetasone | 55 | 200.8 | 201.3 |
| Risedronate Sodium | 70 | 164.8 | 165.2 |
| Human Immunoglobulin G | 46 | 150.5 | 150.9 |
| Triamcinolone Acetonide Ointment Usp, 0.05% | 49 | 142.7 | 143.0 |
| Calcium Gluconate | 22 | 114.4 | 114.6 |
| Triamcinolone Acetonide | 49 | 108.1 | 108.2 |
| Cetirizine Hydrochloride Allergy | 46 | 102.5 | 102.7 |
| Cetirizine Hydrochloride Tablets | 46 | 102.5 | 102.6 |
| Leflunomide | 119 | 100.2 | 100.3 |
| Adalimumab-Fkjp | 64 | 98.9 | 99.1 |
| Golimumab | 102 | 97.8 | 97.9 |
| Adalimumab-Aaty | 64 | 96.8 | 97.0 |
| Adalimumab-Adaz | 64 | 86.8 | 86.9 |
| Tocilizumab | 111 | 82.9 | 83.0 |
| Hydroxychloroquine Sulfate | 88 | 75.2 | 75.3 |
| Certolizumab Pegol | 104 | 73.5 | 73.5 |
| Naproxen Sodium Tablet, Coated | 16 | 72.7 | 72.8 |
| Naproxen Sodium, Coated Tablets | 16 | 72.7 | 72.8 |
| Naproxen Sodium 220Mg | 16 | 72.6 | 72.7 |
| Sulfasalazine | 76 | 72.5 | 72.5 |
| Hydroxychloroquine | 70 | 68.5 | 68.5 |
| Abatacept | 107 | 64.7 | 64.7 |
| Naproxen | 69 | 63.9 | 64.0 |
| Cetirizine | 55 | 49.2 | 49.2 |
| Tofacitinib | 97 | 42.2 | 42.2 |
| Pseudoephedrine Hydrochloride | 7 | 40.8 | 40.9 |
| Pseudoephedrine Hcl | 7 | 38.1 | 38.1 |
| Emicizumab | 3 | 14.4 | 14.4 |